Annual CFI
$92.79 M
+$169.88 M+220.36%
December 31, 2023
Summary
- As of February 7, 2025, LEGN annual cash flow from investing activities is $92.79 million, with the most recent change of +$169.88 million (+220.36%) on December 31, 2023.
- During the last 3 years, LEGN annual CFI has risen by +$116.95 million (+483.91%).
- LEGN annual CFI is now at all-time high.
Performance
LEGN Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFI
$329.08 M
+$1.02 B+147.31%
September 30, 2024
Summary
- As of February 7, 2025, LEGN quarterly cash flow from investing activities is $329.08 million, with the most recent change of +$1.02 billion (+147.31%) on September 30, 2024.
- Over the past year, LEGN quarterly CFI has dropped by -$78.43 million (-19.25%).
- LEGN quarterly CFI is now -19.25% below its all-time high of $407.51 million, reached on December 31, 2023.
Performance
LEGN Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFI
-$355.19 M
+$538.15 M+60.24%
September 30, 2024
Summary
- As of February 7, 2025, LEGN TTM cash flow from investing activities is -$355.19 million, with the most recent change of +$538.15 million (+60.24%) on September 30, 2024.
- Over the past year, LEGN TTM CFI has dropped by -$447.98 million (-482.81%).
- LEGN TTM CFI is now -307.18% below its all-time high of $171.44 million, reached on March 31, 2023.
Performance
LEGN TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
LEGN Cash From Investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +220.4% | -19.3% | -482.8% |
| 3 y3 years | +483.9% | -19.3% | -482.8% |
| 5 y5 years | +190.7% | -19.3% | -482.8% |
LEGN Cash From Investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +147.6% | -19.3% | +147.3% | -307.2% | +60.2% |
| 5 y | 5-year | at high | +147.6% | -19.3% | +147.3% | -307.2% | +60.2% |
| alltime | all time | at high | +147.6% | -19.3% | +147.3% | -307.2% | +60.2% |
Legend Biotech Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $329.08 M(-147.3%) | -$355.19 M(-60.2%) |
| Jun 2024 | - | -$695.63 M(+75.6%) | -$893.34 M(+179.7%) |
| Mar 2024 | - | -$396.15 M(-197.2%) | -$319.39 M(-444.2%) |
| Dec 2023 | $92.79 M(-220.4%) | $407.51 M(-294.9%) | $92.79 M(-132.0%) |
| Sep 2023 | - | -$209.07 M(+71.8%) | -$289.79 M(-714.3%) |
| Jun 2023 | - | -$121.68 M(-859.0%) | $47.17 M(-72.5%) |
| Mar 2023 | - | $16.03 M(-35.7%) | $171.44 M(-322.4%) |
| Dec 2022 | -$77.09 M(-60.5%) | $24.93 M(-80.5%) | -$77.09 M(+1298.6%) |
| Sep 2022 | - | $127.89 M(+4847.4%) | -$5.51 M(-97.7%) |
| Jun 2022 | - | $2.58 M(-101.1%) | -$239.07 M(-41.7%) |
| Mar 2022 | - | -$232.50 M(-340.9%) | -$410.33 M(+110.4%) |
| Dec 2021 | -$194.98 M | $96.51 M(-191.3%) | -$194.98 M(-15.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2021 | - | -$105.67 M(-37.4%) | -$230.33 M(+25.7%) |
| Jun 2021 | - | -$168.67 M(+883.5%) | -$183.28 M(+669.4%) |
| Mar 2021 | - | -$17.15 M(-128.0%) | -$23.82 M(-1.4%) |
| Dec 2020 | -$24.17 M(-58.8%) | $61.16 M(-204.3%) | -$24.17 M(-186.0%) |
| Sep 2020 | - | -$58.62 M(+536.4%) | $28.12 M(-57.1%) |
| Jun 2020 | - | -$9.21 M(-47.4%) | $65.55 M(+69.3%) |
| Mar 2020 | - | -$17.50 M(-115.4%) | $38.73 M(-166.0%) |
| Dec 2019 | -$58.65 M(-42.6%) | $113.45 M(-635.3%) | -$58.65 M(-65.9%) |
| Sep 2019 | - | -$21.19 M(-41.2%) | -$172.10 M(+14.0%) |
| Jun 2019 | - | -$36.03 M(-68.6%) | -$150.91 M(+31.4%) |
| Mar 2019 | - | -$114.88 M | -$114.88 M |
| Dec 2018 | -$102.26 M | - | - |
FAQ
- What is Legend Biotech annual cash flow from investing activities?
- What is the all time high annual CFI for Legend Biotech?
- What is Legend Biotech annual CFI year-on-year change?
- What is Legend Biotech quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Legend Biotech?
- What is Legend Biotech quarterly CFI year-on-year change?
- What is Legend Biotech TTM cash flow from investing activities?
- What is the all time high TTM CFI for Legend Biotech?
- What is Legend Biotech TTM CFI year-on-year change?
What is Legend Biotech annual cash flow from investing activities?
The current annual CFI of LEGN is $92.79 M
What is the all time high annual CFI for Legend Biotech?
Legend Biotech all-time high annual cash flow from investing activities is $92.79 M
What is Legend Biotech annual CFI year-on-year change?
Over the past year, LEGN annual cash flow from investing activities has changed by +$169.88 M (+220.36%)
What is Legend Biotech quarterly cash flow from investing activities?
The current quarterly CFI of LEGN is $329.08 M
What is the all time high quarterly CFI for Legend Biotech?
Legend Biotech all-time high quarterly cash flow from investing activities is $407.51 M
What is Legend Biotech quarterly CFI year-on-year change?
Over the past year, LEGN quarterly cash flow from investing activities has changed by -$78.43 M (-19.25%)
What is Legend Biotech TTM cash flow from investing activities?
The current TTM CFI of LEGN is -$355.19 M
What is the all time high TTM CFI for Legend Biotech?
Legend Biotech all-time high TTM cash flow from investing activities is $171.44 M
What is Legend Biotech TTM CFI year-on-year change?
Over the past year, LEGN TTM cash flow from investing activities has changed by -$447.98 M (-482.81%)